Trial Profile
Efficacy, Safety, and Steroid Sparing Effect of Acthar in Patients With Hematologic Manifestations of Systemic Lupus Erythematosus
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 11 Sep 2019 Planned End Date changed from 1 Mar 2019 to 22 May 2019.
- 11 Sep 2019 Planned primary completion date changed from 1 Mar 2019 to 22 May 2019.
- 11 Sep 2019 Status changed from recruiting to withdrawn prior to enrolment.